Watson Pharmaceuticals Inc.

Recent Events

News & Analysis

watson pharmaceuticals inc. - All News and Analysis

• Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter

  Seeking Alpha - 2009-11-08

  Neil Carvin submits: Watson Pharmaceuticals, Inc. WPI earned $0.54 per share in the third quarter of 2009, down from $0.60 in the same quarter of last year. [Note: our per-share numbers are slightly different than the official results because we don't adjust for interest expenses on convertible contingent...

  Tags: Healthcare, Neil Carvin, Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals Q3 2009 Earnings Call Transcript

  Seeking Alpha - 2009-11-04

  Question-and-Answer SessionOperator (Operator's Instructions) Our first question comes from the line of Tim Chiang with FTN Equity. Tim Chiang - FTN Equity Thanks, Paul. Good morning. I wanted to ask you about the metoprolol launch. How has that gone? Did you have significant revenues...

  Tags: Call Transcript, Quarter, Earnings, Micro-K, Pricing, Marketing Research, Marketing, Seeking Alpha, Watson Pharmaceuticals Inc.

• Watson Pharma Look-Ahead to September 2009 Quarterly Results

  Seeking Alpha - 2009-09-23

  Neil Carvin submits: The GCFR Overall Gauge of Watson Pharmaceuticals, Inc. (NYSE: WPI) slipped from 43 to 39 of the 100 possible points in the second quarter of 2009. Our income statement and financial gauge analyses explained in some detail how the score was attained....

  Tags: Healthcare, Neil Carvin, Watson Pharmaceuticals Inc.

• Watson Pharma Financial Gauge Analysis for June 2009 Quarter

  Seeking Alpha - 2009-08-04

  Neil Carvin submits: In an earlier post, we examined Watson Pharmaceuticals' (NYSE: WPI) Income Statement for the June quarter and compared the figures to our "look-ahead" estimates. Second-quarter earnings fell from $0.51 to $0.46 per share, primarily because of the costs to launch the RAPAFLO and Gelnique...

  Tags: Healthcare, Neil Carvin, Watson Pharmaceuticals Inc.

• Watson Pharma Income Statement Analysis for June 2009 Quarter

  Seeking Alpha - 2009-07-30

  Neil Carvin submits: Watson Pharmaceuticals, Inc. (NYSE: WPI) earned $0.46 per share during the three months that ended on 30 June 2009, down from $0.51 in last year's second quarter. This post examines the Income Statement for the quarter and compares it to our "look-ahead" estimates....

  Tags: Healthcare, Neil Carvin, Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript

  Seeking Alpha - 2009-07-29

  Watson Pharmaceuticals, Inc. WPI Q2 2009 Earnings Call Transcript July 29, 2009 8:30 am ET

  Tags: Healthcare, Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript

  Seeking Alpha - 2009-07-29

  Question-and-Answer SessionOperator Operator instructions Your first question comes from Randall Stanicky from Goldman Sachs. Bob - Goldman Sachs Hi, good morning guys. This is actually Bob [ph] on for Randall this morning. Paul just quickly on the guidance, I guess could you may be help us understand, what gives...

  Tags: Goldman Sachs Group Inc., Call Transcript, Earnings, Watson Pharmaceuticals Inc., Federal Government, Government, Seeking Alpha

• Watson Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript

  Seeking Alpha - 2009-05-04

  Earnings Call ExcerptWatson Pharmaceuticals, Inc. WPI Q1 2009 Earnings Call April 30, 2009 08:30 am ET Executives Patty Eisenhaur - Executive Director IR Paul Bisaro - President and CEO Mark Durand - CFO David Buchen - General Counsel Analysts Marc Goodman - UBS Greg Gilbert - Banc of America...

  Tags: Call, Call Transcript, Earnings, Watson Pharmaceuticals Inc., Financial Accounting, Finance, Seeking Alpha

• Watson Pharmaceuticals, Inc. Q4 2008 Earnings Call Transcript

  Seeking Alpha - 2009-02-19

  Question-and-Answer SessionOperator Operator instructions We’ll pause for just a moment to compile the Q&A roster. Your question comes from Greg Gilbert with Bank of America. Paul Bisaro Hey, Greg. Greg Gilbert – Bank of America Hey, thanks. Good morning. Paul, you slipped in a comment about pricing improving, given...

  Tags: Bank Of America Corp., Call Transcript, Earnings, Federal Government, Finance, Financial Accounting, Government, Marketing, Marketing Research, Pricing, Pricing Strategy, Seeking Alpha, Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals: A Potent Drug Combination

  Seeking Alpha - 2009-01-06

  Paul Price submits: Watson WPI develops, manufactures and markets both generic and branded drugs. It also holds a 50% interest in Somerset Pharmaceuticals a joint venture with Mylan Labs MYL. It previously had acquired Andrx Group in November 2006, bringing its stable of marketed products to...

  Tags: Healthcare, Paul Price, Mylan Inc., Watson Pharmaceuticals Inc.